Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older, of any gender
- People who have been diagnosed with advanced stomach cancer confirmed by a tissue or cell sample, including those whose cancer came back or got worse more than 6 months after completing follow-up cancer treatment
- People who have at least one area of cancer that can be measured on a scan, meeting specific size requirements set by standard imaging guidelines
- People whose treating doctor determines that the study medications (camrelizumab or apatinib) are appropriate for them
- People who are willing to join voluntarily, follow the study instructions, and attend follow-up appointments
Who may not be able to join:
- People who are pregnant or currently breastfeeding
- People who have previously received certain immune-boosting cancer treatments, such as drugs that target PD-1, PD-L1, or CTLA4 (types of immunotherapy)
- People who have previously been treated with medications that work by blocking blood vessel growth in tumours (such as apatinib or similar drugs)
- People who the trial doctor considers unsuitable for the study for any other reason (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Objective response rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.